Hospitals earn a greater profit from physician-administered drugs than pharmaceutical manufacturers themselves, according to a recent analysis by the Partnership for Health Analytic Research.
Pharmacy
The American Clinical Laboratory Association sent a letter to the FDA Sept. 18 calling the agency's recent regulations on reporting genetic testing results to patients "inappropriate" and "troubling."
A former compliance officer at McKesson is under criminal investigation for allegedly conspiring to illegally distribute narcotics, according to The Washington Post.
Walgreens agreed Sept. 17 to settle a class-action lawsuit alleging it violated antitrust laws by restricting search advertisements, according to Digital News Daily.
Sandoz, the generic arm of Novartis, is stopping worldwide distribution of its heartburn medicine that contains high levels of a cancer-causing impurity, according to STAT.
Advertisement
The FDA announced Sept. 17 a project that aims to give cancer patients access to cancer drugs at a quicker rate.
A class of commonly prescribed antibiotics, fluoroquinolones, cause an increased risk of heart valve problems, according to a new study published in the Journal of the American College of Cardiology.
Several U.S. senators sent a letter to the Federal Trade Commission asking it to closely scrutinize large pharmaceutical mergers and acquisitions according to STAT.
Although rebates for brand-name drugs in Medicare Part D substantially reduced drug spending, the rebates were not enough to offset major spikes in drug prices, according to a new study from Office of Inspector General cited by STAT.
Patients with a rare, but potentially fatal calcium-depleting disease are left in limbo with the recall of a critical medicine, according to NBC 5.